PACE-CME

Three lines of evidence for triglycerides as a CV risk factor

Three lines of evidence for triglycerides as a CV risk factor
RestartResume
10' education - Dec. 17, 2019 - Prof. Ph. Gabriel Steg
  • Overview

    Steg outlines how epidemiological evidence pointed at TG as a CV risk factor, which was confirmed by genetic evidence and now further supported by interventional trial evidence.

  • Educational information

    This educational video is part of a series called '4 Things a cardiologist needs to know about triglycerides' that is aimed to guide cardiologists in how triglycerides affect CV risk and how patients with high triglyceride levels can be managed according to recent insights.

  • Faculty

    Ph. Gabriel Steg is a cardiologist in the Hôpital Bichat, Paris, France. He is also Professor at the National Heart and Lung Institute, Imperial College, London, UK.

  • Disclosures

    This educational series is funded by an unrestricted educational grant provided by Amarin.

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free